Indcon Pharma Limited

Founded in 2002 and headquartered in Delhi, India.

2002 | Delhi (India) | Active
Last Updated: January 09, 2025

Indcon Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.96 M
  • Company Age 22 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth 104.24%
  • Profit Growth 123.88%
  • Ebitda -109.40%
  • Net Worth 128.14%
  • Total Assets 53.13%

About Indcon Pharma

Indcon Pharma Limited (IPL) is a Public Limited Indian Non-Government Company incorporated in India on 08 March 2002 and has a history of 22 years and 11 months. Its registered office is in Delhi, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.96 M, as per Ministry of Corporate Affairs (MCA) records.

Prabhas Misra, Usha Misra, and Divya Misra serve as directors at the Company.

Company Details

  • Location

    Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U85110DL2002PLC114517

  • Company No.

    114517

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    08 Mar 2002

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Delhi

Industry

Healthcare

Who are the key members and board of directors at Indcon Pharma?

Board Members (3)

Name Designation Appointment Date Status
Prabhas Misra Country flag representing In Director 08-Mar-2002 Current
Usha Misra Country flag representing In Director 08-Mar-2002 Current
Divya Misra Country flag representing In Director 09-Sep-2009 Current

Financial Performance of Indcon Pharma.

Indcon Pharma Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 104.24% increase. The company also saw a substantial improvement in profitability, with a 123.88% increase in profit. The company's net worth Soared by an impressive increase of 128.14%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
104.24%
Revenue from Operations
Total Assets
53.13%
Profit or Loss
123.88%
Net Worth
128.14%
EBITDA
-109.40%

What is the Ownership and Shareholding Structure of Indcon Pharma?

Unlock access to Indcon Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Indcon Pharma?

Unlock and access historical data on people associated with Indcon Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Indcon Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indcon Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Indcon Pharma

Recent activity within the organization

  • Annual General Meeting

    Indcon Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Indcon Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.

    31 Mar 2024

  • Director Appointment

    Divya Misra was appointed as a Director was appointed as a Director on 09 Sep 2009 & has been associated with this company since 15 years 5 months .

    09 Sep 2009

  • Director Appointment

    Prabhas Narain Misra was appointed as a Director was appointed as a Director on 08 Mar 2002 & has been associated with this company since 22 years 11 months .

    08 Mar 2002

  • Director Appointment

    Usha Rani Misra was appointed as a Director was appointed as a Director on 08 Mar 2002 & has been associated with this company since 22 years 11 months .

    08 Mar 2002

  • Company Incorporation

    Indcon Pharma Limited was registered on 08 Mar 2002 with Roc Delhi & aged 22 years 11 months as per MCA records.

    08 Mar 2002

Frequently asked questions

  • Indcon Pharma Limited was incorporated on 08 Mar 2002.

  • The authorized share capital of Indcon Pharma Limited is ₹ 1.00 M and paid-up capital is ₹ 0.96 M.

  • Currently 3 directors are associated with Indcon Pharma Limited.

    • Prabhas Narain Misra
    • Usha Rani Misra
    • Divya Misra
  • As per Ministry of Corporate Affairs (Mca), the registered address of Indcon Pharma Limited is D-9/6 Okhla Indl. Area Phase-I, India, New Delhi, 110020.

  • The corporate identification number (CIN) of Indcon Pharma Limited is U85110DL2002PLC114517 and the company number is 114517 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2020, the revenue trend for Indcon Pharma Limited has risen by 104.24%.

  • The financial reports for the fiscal year 2020 indicates that The net worth of Indcon Pharma Limited has experienced an upsurge of 128.14%.

  • The most recent Balance Sheet for Indcon Pharma Limited was filed with the ROC on 31 Mar 2024.